These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 16700915)
41. Polymorphism of adiponectin (45T/G) and adiponectin receptor-2 (795G/A) in an Iranian population: relation with insulin resistance and response to treatment with pioglitazone in patients with type 2 diabetes mellitus. Namvaran F; Rahimi-Moghaddam P; Azarpira N; Dabbaghmanesh MH Mol Biol Rep; 2012 May; 39(5):5511-8. PubMed ID: 22187345 [TBL] [Abstract][Full Text] [Related]
42. Genetic variation at the lipoprotein lipase locus and plasma lipoprotein and insulin levels in the Québec Family Study. Ukkola O; Garenc C; Pérusse L; Bergeron J; Després JP; Rao DC; Bouchard C Atherosclerosis; 2001 Sep; 158(1):199-206. PubMed ID: 11500192 [TBL] [Abstract][Full Text] [Related]
43. Single-nucleotide polymorphisms in adiponectin, AdipoR1, and AdipoR2 genes: insulin resistance and type 2 diabetes mellitus candidate genes. Bermúdez VJ; Rojas E; Toledo A; Rodríguez-Molina D; Vega K; Suárez L; Pacheco M; Canelón R; Arráiz N; Rojas J; Velasco M Am J Ther; 2013; 20(4):414-21. PubMed ID: 23656997 [TBL] [Abstract][Full Text] [Related]
44. A Variant in ADIPOR2 Is Associated with Increased Free Fatty Acid Levels in Chinese Population. Yang G; Liu N; Hu M; Xin X; Han J; Cai Y; Hu Z; Jia C; Zhang M Metab Syndr Relat Disord; 2016 Sep; 14(7):368-71. PubMed ID: 27348122 [TBL] [Abstract][Full Text] [Related]
45. Improvement of insulin sensitivity after peroxisome proliferator-activated receptor-alpha agonist treatment is accompanied by paradoxical increase of circulating resistin levels. Haluzik MM; Lacinova Z; Dolinkova M; Haluzikova D; Housa D; Horinek A; Vernerova Z; Kumstyrova T; Haluzik M Endocrinology; 2006 Sep; 147(9):4517-24. PubMed ID: 16740970 [TBL] [Abstract][Full Text] [Related]
46. Adiponectin-AdipoR1/2-APPL1 signaling axis suppresses human foam cell formation: differential ability of AdipoR1 and AdipoR2 to regulate inflammatory cytokine responses. Tian L; Luo N; Zhu X; Chung BH; Garvey WT; Fu Y Atherosclerosis; 2012 Mar; 221(1):66-75. PubMed ID: 22227293 [TBL] [Abstract][Full Text] [Related]
47. In treatment-naïve and antiretroviral-treated subjects with HIV, reduced plasma adiponectin is associated with a reduced fractional clearance rate of VLDL, IDL and LDL apolipoprotein B-100. Das S; Shahmanesh M; Stolinski M; Shojaee-Moradie F; Jefferson W; Jackson NC; Cobbold M; Nightingale P; Umpleby AM Diabetologia; 2006 Mar; 49(3):538-42. PubMed ID: 16432707 [TBL] [Abstract][Full Text] [Related]
48. Genetic architecture of plasma adiponectin overlaps with the genetics of metabolic syndrome-related traits. Henneman P; Aulchenko YS; Frants RR; Zorkoltseva IV; Zillikens MC; Frolich M; Oostra BA; van Dijk KW; van Duijn CM Diabetes Care; 2010 Apr; 33(4):908-13. PubMed ID: 20067957 [TBL] [Abstract][Full Text] [Related]
49. Polymorphisms of ADIPOR1 and ADIPOR2 are associated with phenotypes of type 2 diabetes in Koreans. Kim JT; Kim Y; Cho YM; Koo BK; Lee EK; Shin HD; Jang HC; Choi JW; Oh B; Park KS Clin Endocrinol (Oxf); 2009 Jan; 70(1):66-74. PubMed ID: 18466348 [TBL] [Abstract][Full Text] [Related]
50. Adiponectin downregulates its own production and the expression of its AdipoR2 receptor in transgenic mice. Bauche IB; Ait El Mkadem S; Rezsohazy R; Funahashi T; Maeda N; Miranda LM; Brichard SM Biochem Biophys Res Commun; 2006 Jul; 345(4):1414-24. PubMed ID: 16729974 [TBL] [Abstract][Full Text] [Related]
51. Adiponectin receptor 1 variants associated with lower insulin resistance in African Americans. Crimmins NA; Woo JG; Kaushal RD; Deka R; Dolan LM; Martin LJ Obesity (Silver Spring); 2007 Aug; 15(8):1903-7. PubMed ID: 17712104 [TBL] [Abstract][Full Text] [Related]
52. Adiponectin receptors gene expression and insulin sensitivity in non-diabetic Mexican Americans with or without a family history of Type 2 diabetes. Civitarese AE; Jenkinson CP; Richardson D; Bajaj M; Cusi K; Kashyap S; Berria R; Belfort R; DeFronzo RA; Mandarino LJ; Ravussin E Diabetologia; 2004 May; 47(5):816-20. PubMed ID: 15105989 [TBL] [Abstract][Full Text] [Related]
54. High-fat diet and glucocorticoid treatment cause hyperglycemia associated with adiponectin receptor alterations. de Oliveira C; de Mattos AB; Biz C; Oyama LM; Ribeiro EB; do Nascimento CM Lipids Health Dis; 2011 Jan; 10():11. PubMed ID: 21244702 [TBL] [Abstract][Full Text] [Related]
56. Association of CDH13 genotypes/haplotypes with circulating adiponectin levels, metabolic syndrome, and related metabolic phenotypes: the role of the suppression effect. Teng MS; Hsu LA; Wu S; Sun YC; Juan SH; Ko YL PLoS One; 2015; 10(4):e0122664. PubMed ID: 25875811 [TBL] [Abstract][Full Text] [Related]
57. Muscle-specific overexpression of AdipoR1 or AdipoR2 gives rise to common and discrete local effects whilst AdipoR2 promotes additional systemic effects. Keshvari S; Henstridge DC; Ng C; Febbraio MA; Whitehead JP Sci Rep; 2017 Feb; 7():41792. PubMed ID: 28145500 [TBL] [Abstract][Full Text] [Related]
58. Interaction between Vascular Endothelial Growth Factor-A (rs2010963) Gene Polymorphisms and Dietary Diversity Score on Cardiovascular Risk Factors in Patients with Metabolic Syndrome. Abbasalizad Farhangi M; Vajdi M; Nikniaz L; Nikniaz Z Lifestyle Genom; 2020; 13(1):1-10. PubMed ID: 31786572 [TBL] [Abstract][Full Text] [Related]
59. Predominance of large VLDL particles in metabolic syndrome, detected by size exclusion liquid chromatography. Lucero D; Zago V; López GH; Cacciagiú L; López GI; Wikinski R; Nakajima K; Schreier L Clin Biochem; 2012 Mar; 45(4-5):293-7. PubMed ID: 22245548 [TBL] [Abstract][Full Text] [Related]